The IL-15RF was constructed by combining IL-15 and IL-15 receptor α (IL-15RA) [198], which together are shown to further improve anti-tumor potency, survival and proliferation in transduced CD8+ T cells compared to IL-15 or IL-15RA alone [199]. The gene discussed is IL15; the disease is neoplasm.